Market Research Reports and Industry Reports

LGC Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

LGC Ltd (LGC) formerly LGC (Teddington) Limited, is a life sciences measurement and testing company which offers reference materials, genomics solutions and analytical testing products and services. Its products portfolio includes AutoGen, DNA extraction instrumentation, DNA extraction kits, Douglas scientific, genotyping chemistry, genotyping instruments, genotyping libraries and others. The company provides services such as genotyping, consultancy, consumer product testing, digital forensic investigation, DNA and RNA extraction services; DNA sequencing, drug and alcohol testing; drug development services, food and agricultural analytical services and others. The company caters to agrigenomics, forensic science, food, government and academia; human genomics, pharma and healthcare and sports sectors. It has operations across the US, Europe, Africa and Asia regions. LGC is headquartered in Teddington, Middlesex, the UK.

LGC Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
LGC Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
LGC Ltd, Medical Devices Deals, 2011 to YTD 2017 8
LGC Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
LGC Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
LGC Genomics To Acquire Bioanalytical Sciences Business Of Quotient BioResearch 10
Private Equity 11
KKR to Acquire LGC from Bridgepoint 11
Partnerships 12
EnviroLogix Enters Into Distribution Agreement With Douglas Scientific 12
Link Technologies Enters Into Distribution Agreement With GeneDesign 13
ChromaDex Enters Into Distribution Agreement With LGC Standards For LoGiCal Reference Standards 14
EnviroLogix Enters Into Co-Development Agreement With Douglas Scientific 15
Life Technologies Enters Into Co-Marketing Agreement With Douglas Scientific 16
Licensing Agreements 17
LGC Enters into Licensing Agreement with Keygene 17
Biosearch Technologies Enters Into Licensing Agreement With Rutgers University For turboFISH Technology 18
Biosearch Technologies Extends Licensing Agreement With University Of Medicine And Dentistry Of New Jersey For Stellaris RNA FISH Technology 19
Biosearch Technologies Enters Into Licensing Agreement With University of Medicine and Dentistry of New Jersey For Nucleic Acid Probe Technology 20
Acquisition 21
LGC Acquires Axolabs 21
LGC to Acquire Biosearch Technologies 22
Biosearch Technologies Acquires Majority Stake In LightSpeed Genomics 23
Management Of Axolabs Acquires The Company 24
LGC Acquires KBioscience 25
LGC Ltd - Key Competitors 26
LGC Ltd - Key Employees 27
LGC Ltd - Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Joint Venture 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List Of Tables


LGC Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 2
LGC Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
LGC Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
LGC Ltd, Medical Devices Deals, 2011 to YTD 2017 8
LGC Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
LGC Genomics To Acquire Bioanalytical Sciences Business Of Quotient BioResearch 10
KKR to Acquire LGC from Bridgepoint 11
EnviroLogix Enters Into Distribution Agreement With Douglas Scientific 12
Link Technologies Enters Into Distribution Agreement With GeneDesign 13
ChromaDex Enters Into Distribution Agreement With LGC Standards For LoGiCal Reference Standards 14
EnviroLogix Enters Into Co-Development Agreement With Douglas Scientific 15
Life Technologies Enters Into Co-Marketing Agreement With Douglas Scientific 16
LGC Enters into Licensing Agreement with Keygene 17
Biosearch Technologies Enters Into Licensing Agreement With Rutgers University For turboFISH Technology 18
Biosearch Technologies Extends Licensing Agreement With University Of Medicine And Dentistry Of New Jersey For Stellaris RNA FISH Technology 19
Biosearch Technologies Enters Into Licensing Agreement With University of Medicine and Dentistry of New Jersey For Nucleic Acid Probe Technology 20
LGC Acquires Axolabs 21
LGC to Acquire Biosearch Technologies 22
Biosearch Technologies Acquires Majority Stake In LightSpeed Genomics 23
Management Of Axolabs Acquires The Company 24
LGC Acquires KBioscience 25
LGC Ltd, Key Competitors 26
LGC Ltd, Key Employees 27
LGC Ltd, Other Locations 28
LGC Ltd, Subsidiaries 28
LGC Ltd, Joint Venture 29

List Of Figures


LGC Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
LGC Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
LGC Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
LGC Ltd, Medical Devices Deals, 2011 to YTD 2017 8

PLGCEP/Suzlon – Rajasthan Solar Power Plant 60 MW – India - Project Profile

Synopsis PLGCEP/Suzlon Rajasthan Solar Power Plant 60 MW India - Project Profile contains information on the scope of the project including project overview and location. The profile also details

USD 75View Report

PLGCEP/Suzlon – Maharashtra Solar Power Plant 70 MW – India - Project Profile

Synopsis PLGCEP/Suzlon Maharashtra Solar Power Plant 70 MW India - Project Profile contains information on the scope of the project including project overview and location. The profile also details

USD 75View Report

Mina Therapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mina Therapeutics Ltd (Mina Therapeutics), a subsidiary of MiNA (Holdings) Ltd is a developer of small activating ribonucleic acid therapeutics that selectively upregulate therapeutic proteins. The companys lead therapeutic, MTL-CEBPA,

USD 250View Report

Mundipharma Pte Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mundipharma Pte Ltd(Mundipharma) is a subsidiary of Mundipharma International Ltd, is a pharmaceutical company that develops and manufactures drugs for the treatment of analgesia, oncology, ophthalmology, respiratory, specialty care and

USD 250View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
Country Code.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Aug 2017
No. of Pages :30
Country :United Kingdom
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube